Finance Watch: Argenx Raises $1.15bn For Efgartigimod Commercialization

FcRn Antibody Fragment Submitted To US FDA In January

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.